Literature DB >> 25579517

Cancer stem cells: an insight and future perspective.

Sandeep Kaur1, Gurdeep Singh, Kirandeep Kaur.   

Abstract

The cancer stem cell (CSC) concept derives from the fact that cancers are dysregulated tissue clones whose continued propagation is vested in a biologically distinct subset of cells that are typically rare. Rare CSCs have been isolated from a number of human tumors, including hematopoietic, brain, colon, and breast cancer. With the growing evidence that CSCs exist in a wide array of tumors, it is becoming increasingly important to understand the molecular mechanisms that regulate self-renewal and differentiation because corruption of genes involved in these pathways likely participates in tumor growth. Understanding the biology of CSCs will contribute to the identification of molecular targets important for future therapies.

Entities:  

Mesh:

Year:  2014        PMID: 25579517     DOI: 10.4103/0973-1482.139264

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  8 in total

1.  MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.

Authors:  Beibei Zhai; Xiaofeng Zhang; Bin Sun; Lu Cao; Linlin Zhao; Jun Li; Naijian Ge; Lei Chen; Haihua Qian; Zhengfeng Yin
Journal:  Tumour Biol       Date:  2015-12-28

Review 2.  The multifaceted role of autophagy in cancer.

Authors:  Ryan C Russell; Kun-Liang Guan
Journal:  EMBO J       Date:  2022-05-10       Impact factor: 14.012

3.  HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma.

Authors:  Carla Micucci; Giulia Matacchione; Debora Valli; Silvia Orciari; Alfonso Catalano
Journal:  Br J Cancer       Date:  2015-10-06       Impact factor: 7.640

4.  Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases.

Authors:  Elia Guadagno; Oreste de Divitiis; Domenico Solari; Giorgio Borrelli; Umberto Marcello Bracale; Alberto Di Somma; Paolo Cappabianca; Marialaura Del Basso De Caro
Journal:  J Exp Clin Cancer Res       Date:  2017-07-14

5.  Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells.

Authors:  Yoona Seo; Yoo-Sun Kim; Kyung Eun Lee; Tai Hyun Park; Yuri Kim
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

6.  Fentanyl Inhibits Tumorigenesis from Human Breast Stem Cells by Inducing Apoptosis

Authors:  Nadir Kocak; Filiz Ozen; Ibrahim Halil Yildirim; Yagmur Duran
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

7.  Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer.

Authors:  Wenjing Du; Lan Ni; Baojun Liu; Ying Wei; Yubao Lv; Sujing Qiang; Jingcheng Dong; Xijun Liu
Journal:  Oncogenesis       Date:  2018-04-25       Impact factor: 7.485

8.  TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin.

Authors:  Xiaohui Zhao; Chao Jiang; Rui Xu; Qingnan Liu; Guanglin Liu; Yan Zhang
Journal:  Cancer Cell Int       Date:  2020-02-14       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.